Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.3390
-0.0010 (-0.29%)
At close: Dec 5, 2025, 4:00 PM EST
0.3325
-0.0065 (-1.92%)
After-hours: Dec 5, 2025, 6:18 PM EST
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $12.12 million as of December 5, 2025. Its market cap has decreased by -55.74% in one year.
Market Cap
12.12M
Enterprise Value
11.85M
1-Year Change
-55.74%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $12.12M, a decrease of -95.84%. That is a compound annual growth rate of -26.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |